MembraneBlue

MembraneBlue is a brand name of trypan blue ophthalmic, approved by the FDA in the following formulation(s):

MEMBRANEBLUE (trypan blue - solution; ophthalmic)

• 
  Manufacturer: DORC
  
  Approval date: February 20, 2009
  
  Strength(s): 0.15% ^[RLD]

Has a generic version of MembraneBlue been approved?

No. There is currently no therapeutically equivalent version of MembraneBlue available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of MembraneBlue. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with MembraneBlue.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • December 16, 2011 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• MembraneBlue Advanced Consumer Information (Micromedex)
• Vision Blue Consumer Information (Drugs.com)
• Trypan blue Intraocular Advanced Consumer Information (Micromedex)